Skip to content

Medical emergency? What to do

Stem Cell Therapy Improves Heart Function After MI

3-RXPublished November 14, 20053 min read

Key points

  • Patients with impaired ventricular function following a myocardial infarction may be able to pump new life into damaged heart muscle with an infusion of their own bone marrow-derived progenitor cells.
  • Moreover, patients who received the stem cell infusions five or more days after myocardial infarction had a 7% improvement in left-ventricular ejection function compared with a 1.9% improvement in placebo patients who were infused with acellular serum at least five days after heart attack (P=0.004), Dr.
  • As might be expected, patients with the most significant ischemic damage following MI benefited the most from the progenitor cell therapy, said co-author Volker Scha"chinger, M.D., of the Frankfurt group.
  • At four months clinical follow-up "all major hazard ratios -- myocardial infarction, revascularization, and rehospitalization -- favored the bone-marrow group," he said.

Patients with impaired ventricular function following a myocardial infarction may be able to pump new life into damaged heart muscle with an infusion of their own bone marrow-derived progenitor cells.

In a placebo-controlled trial, patients who received an infusion of the recycled cells improved their global left ventricular function by 5.5%, versus a 3% improvement in patients who received placebo infusions (P=0.014), according to Andreas M. Zeiher, M.D., of J.W. Goethe University in Frankfurt, Germany.

Moreover, patients who received the stem cell infusions five or more days after myocardial infarction had a 7% improvement in left-ventricular ejection function compared with a 1.9% improvement in placebo patients who were infused with acellular serum at least five days after heart attack (P=0.004), Dr. Zeiber reported at the American Heart Association's meeting here today.

Dr. Zeiher said the stem cell infusion is the first therapy "that has the potential to not only limit damage, but also regenerate heart function."

As might be expected, patients with the most significant ischemic damage following MI benefited the most from the progenitor cell therapy, said co-author Volker Scha"chinger, M.D., of the Frankfurt group.

The investigators randomized 95 patients to the bone marrow cell treatment and 92 to placebo. All patients underwent bone marrow aspiration at three to five days after an MI and infusions were done on days three to six.

At four months clinical follow-up "all major hazard ratios -- myocardial infarction, revascularization, and rehospitalization -- favored the bone-marrow group," he said.

Timothy Gardner, M.D., who is chair of the AHA's program committee and is medical director at the Center for Heart and Vascular Health of the Christiana Care Health System in Wilmington, Del., cautioned that the results should be interpreted carefully.

"It is unclear -- at least to me -- if the benefit is caused by an immune reaction to the treatment, which would stimulate growth factors or it is a direct result of the treatment," Dr. Gardner said. But that aside he pointed out that the study was well-designed, "placebo controlled and multicenter."

Dr. Scha"chinger countered by pointing out that even though patients in both groups were infused -- a procedure that could trigger an immune response - "there was an added benefit in the patients who received the bone marrow cell infusions over the placebo."

The study, Reinfusion of Enriched Progenitor Cells And Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI), enrolled patients after they had completed successful acute reperfusion therapy for acute ST elevation MI.

At baseline the average ejection fraction was 47% in the placebo group and 48% in the bone marrow arm.

At four months, 41 patients in the bone marrow arm had LVEF below 49% compared with 52 patients in the placebo arm (P=0.002), Dr. Scha"chinger said.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underHeart

Keep reading

Heart

Early sexual abuse increases heart risks

Women who were repeatedly sexually abused as girls have a 62 percent higher risk of heart problems later in life compared with women who were not abused, U.S. researchers said on Sunday. The findings, presented at…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.